Alvotech (ALVOW) Net Income towards Common Stockholders (2021 - 2025)

Alvotech (ALVOW) reported Net Income towards Common Stockholders of $309.5 million for Q4 2025, up 252.25% on a YoY basis from $87.9 million in Q4 2024, and up 212.19% quarter-over-quarter from -$275.9 million in Q3 2025.

Alvotech (ALVOW) Net Income towards Common Stockholders (2021 - 2025) Analysis & Trends

Alvotech has reported Net Income towards Common Stockholders for 5 years, with the latest figure at $309.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders rose 252.25% year-over-year to $309.5 million; the trailing twelve-month figure through Dec 2025 stood at $136.3 million (up 136.23% YoY), and the FY2025 full-year result was $27.9 million, up 112.04% from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 stood at $309.5 million, up from -$275.9 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $327.9 million in Q2 2025, with the low at -$750.4 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$117.0 million across 5 years, with a median of -$121.4 million in 2022.
  • The largest YoY upside for Net Income towards Common Stockholders was 321.33% in 2025 against a maximum downside of 99900.0% in 2025.
  • Alvotech's Net Income towards Common Stockholders stood at $254.0 million in 2021, then sank by 332.15% to -$589.7 million in 2022, then declined by 27.24% to -$750.4 million in 2023, then soared by 72.91% to -$203.3 million in 2024, then surged by 252.25% to $309.5 million in 2025.
  • The last three Net Income towards Common Stockholders figures came in at $309.5 million (Q4 2025), -$275.9 million (Q3 2025), and $327.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -92.12 Mn
10 Alvotech - - -22.39 Mn 309.47 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 309.47 Mn
Sep 30, 2025 -275.85 Mn
Jun 30, 2025 327.90 Mn
Mar 31, 2025 -225.17 Mn
Dec 31, 2024 -203.26 Mn
Sep 30, 2024 -24.75 Mn
Jun 30, 2024 -148.15 Mn
Mar 31, 2024 -225,167.00
Dec 31, 2023 -750.37 Mn
Aug 31, 2023 -136.71 Mn
Jun 30, 2023 -136.40 Mn
Mar 31, 2023 -305,560.00
Dec 31, 2022 -589.71 Mn
Aug 31, 2022 -201.54 Mn
Jun 30, 2022 -106.41 Mn
Mar 31, 2022 -95.14 Mn
Dec 31, 2021 254.02 Mn
Sep 30, 2021 -103.35 Mn